Patent · US Active

Composition and method for treating acute respiratory tract infections

US10471084B2 · kind B2 · utility

2Cited by

0References

18Claims

0Family size

Assignee

GLYCOM A/S · DK

Inventors

Bruce McConnell · La Tour-de-Peilz, CH
Louise Kristine Vigsnæs · Middelfart, DK

Key dates

Filing date	Mar 4, 2016
Grant date	Nov 12, 2019
Priority date	—
Expiry date	Mar 4, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition and method for using it to prevent and/or relieve symptoms of acute respiratory tract infections, particularly bronchitis, in immune-compromised persons, particularly adults. The composition contains 2′-fucosyllactose and lacto-N-neotetraose and/or lacto-N-tetraose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.